ArticleCellular reprogramming2020
Reprogramming of Pluripotency-Specific microRNA Signatures Is Not Essential to Generate Inducible Pluripotent Stem Cells.
Maria Skamagki, Cheng Zhang, Zhong Liu, Hu Li, Rui Zhao, Kitai Kim
Abstract readLetter
In one paragraphArticle in Cellular reprogramming, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Maria SkamagkiCancer Biology and Genetics Program, Center for Cell Engineering, Center for Stem Cell Biology, Sloan-Kettering Institute, Cell and Developmental Biology Program, Weill Medical College of Cornell University, New York, New York.
Cheng ZhangDepartment of Molecular Pharmacology and Experimental Therapeutics, Center for Individualized Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
Zhong LiuDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, Alabama.
Hu LiDepartment of Molecular Pharmacology and Experimental Therapeutics, Center for Individualized Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
Rui ZhaoDepartment of Biochemistry and Molecular Genetics, Stem Cell Institute, University of Alabama at Birmingham, Birmingham, Alabama.
Kitai KimCancer Biology and Genetics Program, Center for Cell Engineering, Center for Stem Cell Biology, Sloan-Kettering Institute, Cell and Developmental Biology Program, Weill Medical College of Cornell University, New York, New York.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MA new hypothesis: role of p53 inhibitory factors in cellular reprogrammingR01AG043531 · NIA · SLOAN-KETTERING INST CAN RESEARCH · PI KIM, KITAI · 2014 to 2018
$2.3MExplore the APOE e4-mediated p53 activation in Alzheimer's DiseaseR01OD026594 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LI, WEI, ZHAO, RUI · 2019 to 2022
$1.7MHematopoietic potential of histocompatible embryonic stem cell linesR00HL093212 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI KIM, KITAI · 2012 to 2014
$717kModeling low-grade gliomas using human pluripotent stem cellsR21NS106430 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HAN, XIAOSI, ZHAO, RUI · 2018 to 2019
$408kNCI NIH HHS P30 CA008748NHLBI NIH HHS R00 HL093212NIA NIH HHS R01 AG043531NIH HHS R01 OD026594NINDS NIH HHS R21 NS106430
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
MicroRNAsAnimalsCellular ReprogrammingGene Expression ProfilingGenomic InstabilityGlutathioneHumansInduced Pluripotent Stem CellsMiceModels, AnimalGlutathioneMicroRNAs
Identifiers
PMID32011920
PMCPMC7041330
What OpenQuestion holds
Textmetadata
Read underepoch 390